DAE HWA (Korea) Today
| 067080 Stock | KRW 10,930 190.00 1.77% |
PerformanceVery Weak
| Odds Of DistressLow
|
DAE HWA is trading at 10930.00 as of the 26th of February 2025, a 1.77 percent increase since the beginning of the trading day. The stock's open price was 10740.0. DAE HWA has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of November 2024 and ending today, the 26th of February 2025. Click here to learn more.
DAE HWA Pharmaceutical Co., Ltd. researches, develops, produces, and supplies pharmaceutical solutions in South Korea. The company has 17.53 M outstanding shares. More on DAE HWA Pharmaceutical
Moving against DAE Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
DAE Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. DAE HWA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding DAE HWA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Director | Kim EunSeok |
| Business Concentration | Health Care, Pharmaceuticals (View all Sectors) |
DAE HWA Pharmaceutical (067080) is traded on KOSDAQ in Korea and employs 19 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 147.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DAE HWA's market, we take the total number of its shares issued and multiply it by DAE HWA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. DAE HWA Pharmaceutical has 17.53 M outstanding shares.
DAE HWA Pharmaceutical has accumulated about 3.96 B in cash with 10.45 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 360.37.
Check DAE HWA Probability Of Bankruptcy
Ownership AllocationDAE HWA holds a total of 17.53 Million outstanding shares. DAE HWA Pharmaceutical retains serious amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check DAE Ownership Details
DAE HWA Pharmaceutical Risk Profiles
Although DAE HWA's alpha and beta are two of the key measurements used to evaluate DAE HWA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.42 | |||
| Standard Deviation | 3.43 | |||
| Variance | 11.78 | |||
| Risk Adjusted Performance | (0.04) |
DAE Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in DAE HWA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
DAE HWA Corporate Directors
| JaeKwon Yang | Head Director | Profile | |
| BoonYeon Ahn | Head Director | Profile | |
| YoungTaek Park | Head Director | Profile | |
| KwonSuk Han | Managing Director | Profile |
Other Information on Investing in DAE Stock
DAE HWA financial ratios help investors to determine whether DAE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DAE with respect to the benefits of owning DAE HWA security.